16th BENEfit User Meeting

MARPE – THE UPDATE Evidence · Innovation · Classe III-Correction
Still so many questions:
Where to insert?
How many TADs?
Activation Protocol?
Age Limits?
Retention?
Airway?

CONGRESS - Orthodontics

16th BENEfit User Meeting | 23rd-24th April 2027

TOPICS:

Hands-on courses featuring live treatments and practical insights into the use of palatal Mini-Implants.
High-profile international speakers will present the latest developments in MARPE and Class III correction.
Round-table discussion with internationally recognised speakers

Language:

English

Discover a varied programme featuring top-class speakers, practical insights and valuable exchanges within the international BENEfit® community.

We look forward to meeting you!

Speakers

Schedule of the Congress

Prof Dr Benedict Wilmes,
Dr Maximilian Küffer

Basics, Tips & Tricks for palatal TADs use, for starters and users, with live patient.

Trouble shooting.

9 a.m.

- 12:30 p.m.

Dr. Won Moon

Extreme Case Managements and Advanced
Non-surgical Orthopedic Correction

1:30 p.m.

- 5 p.m.

Prof Dr Benedict Wilmes
(Düsseldorf, Germany):

Welcome

9 a.m.

Prof Dr Won Moon
(Los Angeles, USA):

AI-driven Digital Fabrication of Maxillary Skeletal Expander (MSE) and the Latest Updates.

9:15 a.m.

Prof Dr Kee-Joon Lee (Seoul, Korea):

Myths and truths in MARPE in adults for maximum success.

09:45 a.m.

Prof Dr Sercan Akyalcin (Harvard Boston, USA):

Expanding Possibilities Beyond the Palate with MARPE.

10:15 a.m.

Coffee Break

10:45 h

Dr Kenji Ojima
(Tokyo, Japan):

MARPE & Aligners, how to combine?

11:15 a.m.

Dr Heinz Winsauer (Bregenz, Austria):

“Bone first principle”: Can pre-fabricated expanders meet this challenge?

11:45 a.m.

Dr Giorgio Iodice
(Napel, Italy):

MARPE: Between Scientific Evidence and Social Media Trends.

12:15 p.m.

Lunch Break

12:45 p.m.

Prof Dr Daniela Garib (Sao Paulo, Brazil):

Mini-Screw Anchored Maxillary Protraction: Clinical Outcomes in the Short and Long-Term.

13:45 p.m.

Dr Monika Walerzak (Warsaw, Poland):

Class III Growth Modification in the Digital Era: From Diagnosis to Skeletal Anchorage.

14:15 p.m.

Dr Nour Tarraf
(Sydney, Australia):

Growing Class III patients: rethinking timing, Diagnosis and treatment.

14:45 p.m.

Coffee Break

15:15 p.m.

Prof Dr Dieter Drescher (Düsseldorf, Germany:

Class III therapy in growing patients – what, when, why?

15:45 p.m.

Prof Dr Ravi Nanda (Connecticut, USA):

Class III treatment in growing patients – timing and prognosis.

Round Table Discussion

16:15 p.m

Deadline Poster-Abstract: 31st January 2027

Register now for the 16th BENEfit®
User Meeting

If you have any questions
please write to:
congress@bb-mc.com

Prices

FRIDAY

Morning Session & Afternoon Session:

€ 290 each(Standard tariff)
€ 240 each (Postgraduates tariff)

Prices include lunch, coffee breaks and a get-together on Friday.
All fees are plus 19% VAT.

SATURDAY

16th BENEfit® User Meeting:

€ 490 each (Standard tariff)
€ 360 each (Postgraduates tariff)

BENEfit® Party:

€ 95 (Normal tariff)
€ 70 (Postgraduates tariff)

The Venue

Hotel Kö59 | Königsallee 59
40215 Düsseldorf, Germany

Special room rates (available until 10th March 2027): Single room: € 200 | Double room € 230. Booking-Code: „BENEfit User Meeting”

Afternoon-Programme

BENEfit Party: Canoo Boat

Buffet, Drinks & Party
Saturday, 24th April 2027
20:00 p.m. – 02:00 a.m.

The boat stops and does not leave.

Canoo-Club | Robert-Lehr-Ufer 19
40474 Düsseldorf, Germany

www.canoo-club.de

Many thanks to our sponsors

Flyer

Download the flyer for the 15th BENEfit® User Meeting 2025 here.

Video from the 15. BENEfit® User Meeting 2025

Did you miss this meeting with outstanding speakers? The recording of the 15th Benefit Users’ Meeting is now available!

15. BENEfit User Meeting: € 290
Wilmes/Björn Ludwig: € 290
(plus. 19% MwSt.)

After ordering, you will receive all the details and an invoice. After payment, you will have the opportunity to enjoy all the presentations and the remarkable discussion.

16th BENEfit User Meeting

MARPE – THE UPDATE Evidence · Innovation · Classe III-Correction Still so many questions: Where to insert? How many TADs? Activation Protocol? Age Limits? Retention? Airway?